Is open surgery for head and neck cancers truly declining?

European Archives of Oto-Rhino-Laryngology

Volumn 270, Issue 11, 2013, Pages 2793-2802

  Hartl, Dana M ^a,b   Brasnu, Daniel F ^c   Shah, Jatin P ^d   Hinni, Michael L ^e   Takes, Robert P ^f   Olsen, Kerry D ^g   Kowalski, Luiz P ^h   Rodrigo, Juan P ^i,j   Strojan, Primož ^k   Wolf, Gregory T ^l   Rinaldo, Alessandra ^m   Suárez, Carlos ^i,j   Mendenhall, William M ⁿ   Paleri, Vinidh ^o   Forastiere, Arlene A ^p   Werner, Jochen A ^q   Ferlito, Alfio ^m  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Laboratoire de Phonetique et de Phonologie   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e MAYO CLINIC   (United States)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g MAYO CLINIC   (United States)

^h A C CAMARGO CANCER CENTER   (Brazil)

ⁱ HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^j DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^k INSTITUTE OF ONCOLOGY   (Slovenia)

^l UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^m UNIVERSITY OF UDINE   (Italy)

ⁿ UNIVERSITY OF FLORIDA   (United States)

^o NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^p JOHNS HOPKINS UNIVERSITY   (United States)

^q PHILIPPS UNIVERSITY MARBURG   (Germany)

more..

Author keywords

Endoscopic surgery; Head and neck cancer; Minimally invasive surgery; Open surgery; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; TAXANE DERIVATIVE;

ALLOTRANSPLANTATION; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL TRIAL (TOPIC); CONSERVATIVE TREATMENT; EAR NOSE THROAT SURGERY; ENDOSCOPE; ENDOSCOPIC SURGERY; FREE TISSUE GRAFT; GASTROSTOMY; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEAD AND NECK SURGERY; HUMAN; HYPOPHARYNX CANCER; INCIDENCE; INDUCTION CHEMOTHERAPY; LARYNGECTOMY; LARYNX CANCER; LASER; LASER SURGERY; MELANOMA; MICROSCOPE; MINIMALLY INVASIVE SURGERY; MOLECULARLY TARGETED THERAPY; MOUTH CANCER; NECK DISSECTION; NON MELANOMA SKIN CANCER; OROPHARYNX CANCER; OVERALL SURVIVAL; PARANASAL SINUS CANCER; POSTOPERATIVE CARE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; ROBOTICS; SALIVARY GLAND CANCER; SALVAGE THERAPY; SARCOMA; SKIN CANCER; SKULL BASE TUMOR; THYROID CANCER; THYROIDECTOMY; TISSUE ENGINEERING; TONSILLECTOMY; TRACHEOSTOMY; TRANSORAL ROBOTIC ASSISTED SURGERY; TREATMENT INDICATION; VIRUS CARCINOGENESIS; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; ENDOSCOPY; HEAD AND NECK NEOPLASMS; HUMANS; LASER THERAPY; NECK DISSECTION; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 84885959761     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-012-2322-y     Document Type: Review

References (82)

1. Silver CE, Beitler JJ, Shaha AR, Rinaldo A, Ferlito A (2009) Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 266:1333-1352
2. Takes RP, Strojan P, Silver CE et al (2012) Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck 34:270-281
3. Haigentz M Jr, Silver CE, Corry J et al (2009) Current trends in initial management of oropharyngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 266:1845-1855
4. Bonifazi M, Malvezzi M, Bertuccio P et al (2011) Age-period-cohort analysis of oral cancer mortality in Europe: the end of an epidemic? Oral Oncol 47:400-407
5. Davies L, Welch HG (2006) Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg 135:451-457
6. Oxford Cancer Intelligence Unit (2010) Profile of head and neck cancers in England. Incidence, mortality and survival. (http://www.ociu.nhs.uk)
7. Curado MP, Hashibe M (2009) Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 21:194-200
8. Ligier K, Belot A, Launoy G et al (2011) Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980-2005 and projection to 2010. Oral Oncol 47:302-307
9. Gillespie MB, Rubinchik S, Hoel B, Sutkowski N (2009) Human papillomavirus and oropharyngeal cancer: what you need to know in 2009. Curr Treat Options Oncol 10:296-307
10. Johnson-Obaseki S, McDonald JT, Corsten M, Rourke R (2012) Head and neck cancer in Canada: trends 1992-2007. Otolaryngol Head Neck Surg 147:74-78
11. Hocking JS, Stein A, Conway EL et al (2011) Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 104:886-891
12. Blomberg M, Nielsen A, Munk C, Kjaer SK (2011) Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites. Int J Cancer 129:733-741
13. Näsman A, Attner P, Hammarstedt L et al (2009) Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125:362-366
14. Chaturvedi AK, Engels EA, Pfeiffer RM et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29:4294-4301
15. Sobin LH, Gospodarowicz MK, Wittekind C (eds) (2010) UICC International Union Against Cancer. TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, West Sussex
16. Wang CC (1976) Cancer of the larynx: radiation therapy. CA Cancer J Clin 26:212-218
17. Fein DA, Mendenhall WM, Parsons JT, Million RR (1993) T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control. Int J Radiat Oncol Biol Phys 25:605-611
18. Bradley PJ, Mackenzie K, Wight R, Pracy P, Paleri V (2009) Consensus statement on management in the UK: transoral laser assisted microsurgical resection of early glottic cancer. Clin Otolaryngol 34:367-373
19. Higgins KM, Shah MD, Ogaick MJ, Enepekides D (2009) Treatment of early-stage glottic cancer: meta-analysis comparison of laser excision versus radiotherapy. J Otolaryngol Head Neck Surg 38:603-612
20. Stoeckli SJ, Schnieper I, Huguenin P, Schmid S (2003) Early glottic carcinoma: treatment according patient's preference? Head Neck 25:1051-1056
21. Hartl DM, Ferlito A, Brasnu DF et al (2011) Evidence-based review of treatment options for patients with glottic cancer. Head Neck 33:1638-1648
22. Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091-2098
23. Pfister DG, Laurie SA, Weinstein GS et al (2006) American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24:3693-3704
24. Paleri V, Thomas L, Basavaiah N, Drinnan M, Mehanna H, Jones T (2011) Oncologic outcomes of open conservation laryngectomy for radiorecurrent laryngeal carcinoma: a systematic review and meta-analysis of English-language literature. Cancer 117:2668-2676
25. The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690
26. Pointreau Y, Garaud P, Chapet S et al (2009) Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101:498-506
27. Bonner JA, Harari PM, Giralt J et al (2010) Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 11:21-28
28. Vilaseca I, Blanch JL, Bernal-Sprekelsen M (2012) Transoral laser surgery for hypopharyngeal carcinomas. Curr Opin Otolaryngol Head Neck Surg 20:97-102
29. Park YM, Kim WS, De Virgilio A, Lee SY, Seol JH, Kim SH (2012) Transoral robotic surgery for hypopharyngeal squamous cell carcinoma: 3-year oncologic and functional analysis. Oral Oncol 48:560-566
30. Lefebvre JL, Andry G, Chevalier D et al (2012) Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891. Ann Oncol 23:2708-2714
31. Blanchard P, Baujat B, Holostenco V et al (2011) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol 100:33-40
32. Posner MR, Norris CM, Wirth LJ et al (2009) Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol 20:921-927
33. Gillison ML, D'Souza G, Westra W et al (2008) Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100:407-420
34. D'Souza G, Kreimer AR, Viscidi R et al (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356:1944-1956
35. Fakhry C, Westra WH, Li S et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261-269
36. Machtay M, Moughan J, Trotti A et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26:3582-3589
37. Haughey BH, Hinni ML, Salassa JR et al (2011) Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck 33:1683-1684
38. Weinstein GS, O'Malley BW Jr, Cohen MA, Quon H (2010) Transoral robotic surgery for advanced oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 136:1079-1085
39. Leonhardt FD, Quon H, Abrahão M, O'Malley BW Jr, Weinstein GS (2012) Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient-reported quality of life and function. Head Neck 34:146-154
40. Moore EJ, Olsen SM, Laborde RR et al (2012) Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma. Mayo Clin Proc 87:219-225
41. Quon H, Cohen MA, Montone KT et al (2011) Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16(INK4a)on treatment outcomes. Laryngoscope (Epub ahead of print)
42. Veness MJ, Porceddu S, Palme CE, Morgan GJ (2007) Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck 29:621-631
43. Olsen KD (2010) Reexamining the treatment of advanced laryngeal cancer. Head Neck 32:1-7
44. Urba S, Wolf G, Eisbruch A et al (2006) Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J Clin Oncol 24:593-598
45. Chen AY, Halpern M (2007) Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 133:1270-1276
46. Chen AY, Fedewa S, Zhu J (2011) Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007. Arch Otolaryngol Head Neck Surg 137:1017-1024
47. Hoffman HT, Porter K, Karnell LH et al (2006) Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116(Suppl 111):1-13
48. Hinni ML, Salassa JR, Grant DG et al (2007) Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 133:1198-1204
49. Forastiere AA, Maor M, Weber RS et al (2006) Long-term results of intergroup RTOG 91-11: a phase III trial to preserve the larynx - induction cisplatin/5FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. J Clin Oncol 24(Suppl 18):5517
50. Gourin CG, Conger BT, Sheils WC, Bilodeau PA, Coleman TA, Porubsky ES (2009) The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 119:1312-1317
51. Lund VJ, Stammberger H, Nicolai P et al (2010) European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinol Suppl 22:1-143
52. Lund VJ, Chisholm EJ, Takes RP et al (2012) Evidence for treatment strategies in sinonasal adenocarcinoma. Head Neck 34:1168-1178
53. Cooper JS, Porter K, Mallin K et al (2009) National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 31:748-758
54. Guntinas-Lichius O, Wendt T, Buentzel J et al (2010) Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database. J Cancer Res Clin Oncol 136:55-63
55. de Souza DL, Bernal MM, Curado MP (2012) Trends in the incidence of major salivary gland cancer in Spain (1978-2002). Gac Sanit 26:65-68 [in Spanish]
56. Pinkston JA, Cole P (1999) Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg 120:834-840
57. Gourin CG, Frick KD (2012) National trends in laryngeal cancer surgery and the effect of surgeon and hospital volume on short-term outcomes and cost of care. Laryngoscope 122:88-94
58. Gourin CG, Frick KD (2012) National trends in oropharyngeal cancer surgery and the effect of surgeon and hospital volume on short-term outcomes and cost of care. Laryngoscope 122:543-551
59. Tan HK, Giger R, Auperin A, Bourhis J, Janot F, Temam S (2010) Salvage surgery after concomitant chemoradiation in head and neck squamous cell carcinomas - stratification for post salvage survival. Head Neck 32:139-147
60. Taki S, Homma A, Oridate N et al (2010) Salvage surgery for local recurrence after chemoradiotherapy or radiotherapy in hypopharyngeal cancer patients. Eur Arch Otorhinolaryngol 267:1765-1769
61. Nichols AC, Kneuertz PJ, Deschler DG et al (2011) Surgical salvage of the oropharynx after failure of organ-sparing therapy. Head Neck 33:516-524
62. Grant DG, Salassa JR, Hinni ML, Pearson BW, Perry WC (2006) Carcinoma of the tongue base treated by transoral laser microsurgery, part two: persistent, recurrent and second primary tumors. Laryngoscope 116:2156-2161
63. Esteller E, Vega MC, López M, Quer M, León X (2011) Salvage surgery after locoregional failure in head and neck carcinoma patients treated with chemoradiotherapy. Eur Arch Otorhinolaryngol 268:295-301
64. Kim EY, Eisele DW, Goldberg AN, Maselli J, Kezirian EJ (2011) Neck dissections in the United States from 2000 to 2006: volume, indications, and regionalization. Head Neck 33:768-773
65. Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167
66. Simard EP, Ward EM, Siegel R, Jemal A (2012) Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. doi: 10.3322/caac.20141
67. Leiter U, Garbe C (2008) Epidemiology of melanoma and non-melanoma skin cancer-the role of sunlight. Adv Exp Med Biol 624:89-103
68. Zhu C, Zheng T, Kilfoy BA et al (2009) A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004. Thyroid 19:1061-1066
69. Lee S, Ryu HR, Park JH et al (2011) Excellence in robotic thyroid surgery: a comparative study of robot-assisted versus conventional endoscopic thyroidectomy in papillary thyroid microcarcinoma patients. Ann Surg 253:1060-1066
70. Minuto MN, Berti P, Miccoli M et al (2012) Minimally invasive video-assisted thyroidectomy: an analysis of results and a revision of indications. Surg Endosc 26:818-822
71. Brasnu DF, Hartl DM (2008) The laryngologist in organ preservation for laryngeal cancer. Laryngoscope 118:759-760
72. Hartl DM, Cohen M, Juliéron M, Marandas P, Janot F, Bourhis J (2008) Botulinum toxin for radiation-induced facial pain and trismus. Otolaryngol Head Neck Surg 138:459-463
73. Pignon JP, le Maître A, Maillard E, Bourhis J (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4-14
74. Moore EJ, Hinni ML, Olsen KD, Price DL, Laborde RR, Inman JC (2012) Cost considerations in the treatment of oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 146:946-951
75. Deeb R, Sharma S, Mahan M et al (2012) Head and neck cancer in transplant recipients. Laryngoscope 122:1566-1569
76. Strome M, Stein J, Esclamado R et al (2001) Laryngeal transplantation and 40-month follow-up. N Engl J Med 344:1676-1679
77. Knott PD, Hicks D, Braun W, Strome M (2011) A 12-year perspective on the world's first total laryngeal transplant. Transplantation 91:804-805
78. Birchall MA, Ayling SM, Harley R et al (2012) Laryngeal transplantation in minipigs: early immunological outcomes. Clin Exp Immunol 167:556-564
79. Fishman JM, De Coppi P, Elliott MJ, Atala A, Birchall MA, Macchiarini P (2011) Airway tissue engineering. Expert Opin Biol Ther 11:1623-1635
80. Lantieri L (2012) Face transplant: a paradigm change in facial reconstruction. J Craniofac Surg 23:250-253
81. Kaufman CL, Breidenbach W (2011) World experience after more than a decade of clinical hand transplantation: update from the Louisville hand transplant program. Hand Clin 27:417-421 vii-viii
82. Lott DG, Russell JO, Khariwala SS, Dan O, Strome M (2011) Ten-month laryngeal allograft survival with use of pulsed everolimus and anti-alpha beta T-cell receptor antibody immunosuppression. Ann Otol Rhinol Laryngol 120:131-136